A

Agilent Technologies

Provides eProcurement automation and hosted catalogs

Digital Product Specialist

Full-TimeUpdated on 10/2/2026
€27.4k - €42.9k/yr
Entry
Bachelor's, Master's
Turin, Metropolitan City of Turin, Italy
In PersonOccasional travel is required.

About the job

Requirements
  • Recent graduation within the last two years.
  • A Bachelor's or Master's degree in Marketing, Communication, Economics, Engineering, or a similar field.
  • Strong Excel skills.
  • Full fluency in English.
Responsibilities
  • Support the team in creating and publishing digital assets, including web pages.
  • Optimize digital product content and search engine optimization.
  • Work with team members on tactics to promote digital content and improve organic traffic to web pages.
  • Support e-commerce activities, including creating and maintaining e-store content such as images, technical specifications, and filters.
  • Analyze keywords and digital traffic and web-page performance using Google Analytics, Google Search Console, and other company data tools and platforms.
  • Collaborate on digital projects involving web-content migration to new platforms and adaptation to a new user experience.
Desired Qualifications
  • Previous experience in digital marketing and/or search engine optimization.
  • Knowledge of Google Analytics or another data-analysis tool.
  • Fluency in Italian.

About the company

Agilent Technologies provides eProcurement services that help businesses buy supplies more efficiently. It offers a suite of electronic procurement tools that let clients load their pricing into existing purchasing platforms, access a hosted catalog, and complete transactions digitally without paper. The service connects pricing data to clients’ procurement systems, delivers an online catalog, and supports automated, paperless purchasing workflows. This makes purchasing faster and reduces manual steps. Compared with competitors, Agilent emphasizes automation, quick connectivity between pricing, catalogs, and purchasing platforms, and a reliable, scalable experience backed by its broad product range. The company aims to improve client productivity and lower procurement costs, helping customers buy what they need more easily while keeping prices clear and consistent.

Company Size

10,001+

Company Stage

IPO

Headquarters

Santa Clara, California

Founded

1999

Get referred to Agilent Technologies

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q3 FY2026 revenue hit $1.88 billion, up 8.1%, and guidance rose to $7.51 billion.
  • China grew 9% and pharma grew 12%, signaling stronger end markets.
  • September 2026 launches, including S540MD and Gen5 AI, expand higher-value digital pathology.

What critics are saying

  • Tariff refunds added 110 basis points to Q3 margin, masking underlying profitability.
  • FY26 restructuring costs and workforce reductions continue through first-quarter 2027.
  • A failed pathology pivot leaves Agilent overexposed to slower instrument cycles and commoditization.

What makes Agilent Technologies unique

  • Agilent combines instruments, software, and consumables across pathology, imaging, and analytics.
  • The June 2026 Biocare Medical acquisition deepens its pathology menu and clinical reach.
  • June 2026 OpenAI and BCG collaboration pushes AI into products, operations, and workflows.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Remote Work Options

Performance Bonus

Stock Options

Growth & Insights and Company News

Headcount

6 month growth

↑ 0%

1 year growth

↑ 0%

2 year growth

↓ -3%
Business Wire
Sep 29th, 2026
Agilent launches Gen5 AI cell identification module for BioTek automated imagers

Agilent Technologies has launched the BioTek Gen5 AI cell identification module, a new image analysis software add-on for its BioTek automated imaging systems. The module uses AI-based cell identification and segmentation, eliminating the need for conventional threshold setting or parameter tuning. The technology addresses challenges researchers face with threshold-based segmentation, which requires establishing and optimising analysis parameters for individual experiments. This process can introduce user-dependent variation and create difficulties in high-throughput imaging workflows. The module supports label-free and fluorescence applications, as well as live-cell and kinetic assays commonly used in life science and pharmaceutical research. It integrates with Gen5 software, allowing researchers using compatible BioTek Cytation and Lionheart automated imagers to apply AI-based segmentation within existing workflows. Agilent generated revenue of $6.95 billion in fiscal year 2025 and employs approximately 18,000 people worldwide.

Yahoo Finance
Sep 19th, 2026
Agilent launches 540-slide scanner for pathology labs eyeing AI workflows

Agilent Technologies launched the S540MD slide scanner in the United States on 4 September. The FDA-cleared device can hold up to 540 glass slides at once and targets pathology labs managing high sample volumes and preparing for AI-assisted workflows. The scanner automates routine tasks and integrates with existing laboratory setups. It reached select European markets in January and is now available in Germany, the UK, France, and other European countries alongside the US. Agilent reported revenue of $1.88 billion for the quarter ended 31 July, up 8.1% year-on-year. Non-GAAP earnings per share rose 18%. Management raised full-year non-GAAP earnings guidance to $6.18 to $6.21 per share. The S540MD is a rebadged Hamamatsu NanoZoomer S540MD. Agilent has not disclosed pricing or revenue targets for the product.

Associated Press
Sep 8th, 2026
Agilent appoints ex-Stryker CFO Glenn Boehnlein to board, chair Koh Boon Hwee retires

Agilent Technologies announced that Koh Boon Hwee retired from its board of directors on 4 September 2026, after more than 20 years of service. Koh joined the board in 2003 and served as independent chair from 2017 until his retirement. Dow R. Wilson, a board member since 2018, was elected as the new chair. Wilson currently chairs the Audit and Finance Committee. The company also appointed Glenn Boehnlein to its board, effective 4 September 2026. Boehnlein spent 22 years at Stryker Corporation, serving as vice president and chief financial officer from 2016 until his retirement in 2025. He currently serves on the boards of Inogen and Sutter Health.

Associated Press
Sep 1st, 2026
Agilent launches Cary 635 FTIR spectrometer for compact, high-performance lab analysis

Agilent Technologies has launched the Cary 635 FTIR spectrometer, described as the smallest Fourier transform infrared analyser in its class. The compact instrument combines high-performance analysis with user-friendly operation, requiring minimal technical training. The spectrometer features solid ZnSe optical components for enhanced moisture resistance and improved sensitivity for analysing lower-concentration samples. Its modular architecture supports analysis of solids, liquids, powders, and gases, whilst permanently aligned optics enable rapid interchange of sampling modules. The device includes MicroLab software with step-by-step workflows and colour-coded results, allowing novice users to be trained quickly. Agilent generated $6.95 billion in revenue during fiscal year 2025 and employs approximately 18,000 people worldwide.

Yahoo Finance
Aug 29th, 2026
Agilent expands non-GAAP margin 320 bps, but 110 bps came from tariff refunds

Agilent Technologies reported fiscal third-quarter revenue of $1.88 billion, up 8.1% year-over-year. Core revenue, excluding currency movements and M&A activity, grew 7.3%. The company's non-GAAP operating margin reached 28.3%, expanding 320 basis points. However, roughly 110 basis points of that improvement stemmed from tariff refunds, which also added $17 million to non-GAAP net income and approximately $0.06 to earnings per share. Excluding the refunds, operating margin expansion was approximately 210 basis points, supported by higher revenue and operational efficiencies. All three business segments reported revenue growth, with Life Sciences and Diagnostics Markets Group up 11%, CrossLab up 6%, and Applied Markets up 7%. For the full year, Agilent expects non-GAAP operating margin expansion of more than 130 basis points, including roughly 30 basis points from the tariff refunds.